CD4 and neoplasm: Low expressors presented lower response rates to ICIs when compared to the high expressors (16.7%, vs. 60%); moreover, patients whose tumor tissue presented CD8+/CD4+ ratios lower than two showed lower response rates than patients whose tumor tissue presented a >2 ratio RR (13.3% vs. 43 to 50%) [99].